Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2020 Financial Results on March 16, 2021
Organogenesis Holdings Inc. (Nasdaq: ORGO) will announce its fourth quarter and fiscal year 2020 financial results on March 16, 2021, after market closure. A conference call will follow at 5:00 p.m. ET to discuss the financial outcomes and provide corporate updates. Interested participants can join by calling 866-795-3142 (international callers: 409-937-8908) and using access code 6766924. A live webcast will be available on the company's investor relations website, with a replay accessible for two weeks thereafter.
- None.
- None.
CANTON, Mass., Feb. 08, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today announced that fourth quarter and fiscal year 2020 financial results will be reported after the market closes on Tuesday, March 16.
Management will host a conference call at 5:00 p.m. Eastern Time on March 16 to discuss the results of the quarter and the fiscal year, and provide a corporate update with a question and answer session. Those who would like to participate may dial 866-795-3142 (409-937-8908 for international callers) and provide access code 6766924. A live webcast of the call will also be provided on the investor relations section of the Company's website at investors.organogenesis.com.
For those unable to participate, a replay of the call will be available for two weeks at 855-859-2056 (404-537-3406 for international callers); access code 6766924. The webcast will be archived at investors.organogenesis.com.
About Organogenesis Holdings Inc.
Organogenesis Holdings Inc. is a leading regenerative medicine company offering a portfolio of bioactive and acellular biomaterials products in advanced wound care and surgical biologics, including orthopedics and spine. Organogenesis’s comprehensive portfolio is designed to treat a variety of patients with repair and regenerative needs. For more information, visit www.organogenesis.com.
FAQ
When will Organogenesis Holdings report its fourth quarter 2020 financial results?
What time is the conference call for Organogenesis Holdings' financial results?
How can I participate in the Organogenesis Holdings conference call?
Is there a webcast available for the Organogenesis Holdings conference call?
Will there be a replay of the Organogenesis Holdings conference call?
